Also known as: Miracle Alien Cookies #21 · MAC1 #21 (incorrectly) · Capulator's MAC #21

MAC #21

A selected phenotype of MAC (Miracle Alien Cookies) known for symmetrical bag appeal, gassy-floral aroma, and uneven cultivation reports.

Sourced and fact-checked
8 cited sources
Published 4 days ago
How this page was made
↯ The honest take

MAC #21 is a real, selected phenotype from Capulator's MAC line, but most flower sold as 'MAC #21' on the street or in dispensaries has no verifiable connection to that cut. Like most boutique strain names, it's become a marketing label more than a genetic guarantee. The original pheno has a reputation for sour-floral gas and balanced effects, but there is no clinical research on this strain specifically, and cannabinoid/terpene averages vary wildly between grows.

Overview

MAC #21 is one of several named phenotypes pulled from the MAC (Miracle Alien Cookies) seed line bred by Capulator. The broader MAC family became one of the most-hyped American hybrids of the late 2010s, prized for tight, frosty, often variegated buds and a sour, floral, gassy nose [1][2].

'#21' refers to a specific plant selection — historically, growers number keepers from a seed pop (pheno #1, #21, etc.). Unlike MAC1, which is a widely-distributed clone-only cut, MAC #21 has never been formally released as a clone line by Capulator, and most flower labeled 'MAC #21' on the market is either a different grower's seed-hunt keeper or a marketing relabel Disputed.

Chemistry: cannabinoids and terpenes

Published lab data specific to MAC #21 is sparse and inconsistent. Aggregated dispensary COAs for flower sold under the MAC and MAC #21 names typically show:

Terpene profiles vary by grower and pheno, but MAC-family flower is commonly reported as limonene-dominant, with notable beta-caryophyllene and smaller amounts of linalool, humulene, and myrcene Weak / limited. Some chemovars sold as MAC test terpinolene-forward instead, which is a strong hint that not all 'MAC' flower shares the same genetics [3].

The popular claim that a strain needs >0.5% myrcene to be 'sedating' (the so-called myrcene threshold) is folklore — it traces to a single textbook assertion and has never been clinically validated [4] No data.

Reported effects

There are no clinical trials on MAC #21, or on any single cultivar, evaluating effects in humans. Everything below is user-reported on community sites and dispensary menus, not evidence Anecdote.

Common descriptors include: balanced head-and-body, talkative, mood-lifting early followed by relaxation, mild appetite stimulation, dry mouth. Reported negatives include anxiety or paranoia at high doses, which is consistent with the general dose-response pattern for high-THC flower in controlled studies [5].

The indica/sativa label tells you very little about how a strain will actually feel. Chemotype (cannabinoid + terpene profile), dose, set, setting, and individual tolerance dominate the experience — a point repeatedly made by cannabis researchers [3][6].

Lineage

The MAC line's parentage is partially disputed. Capulator has publicly described MAC as Alien Cookies F2 × (Colombian × Starfighter) [1][2]. That cross is the most commonly cited and the one we'd treat as the working answer.

Where it gets murky:

Cultivation basics

Cultivation notes here are aggregated from grower forums and breeder descriptions, not controlled agronomic studies Anecdote.

None of this is MAC #21-specific in a verifiable way — it reflects general MAC-family behavior.

Marketing vs. reality

What's real:

What's marketing:

If you like a particular jar of MAC #21, that's a vote for that specific grower's pheno and cultivation, not a guarantee about the next one you buy.

Sources

  1. Reported Jikomes, N. (2019). 'The Origin and Genetics of MAC (Miracle Alien Cookies).' Leafly.
  2. Reported High Times Staff. (2020). 'Strain of the Year: MAC.' High Times Magazine.
  3. Peer-reviewed Smith, C.J., Vergara, D., Keegan, B., Jikomes, N. (2022). 'The phytochemical diversity of commercial Cannabis in the United States.' PLOS ONE, 17(5): e0267498.
  4. Peer-reviewed Russo, E.B. (2011). 'Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.' British Journal of Pharmacology, 163(7): 1344-1364.
  5. Peer-reviewed Hindocha, C., Freeman, T.P., et al. (2015). 'Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.' Addiction Biology, 20(4): 619-629.
  6. Peer-reviewed Piomelli, D., Russo, E.B. (2016). 'The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD.' Cannabis and Cannabinoid Research, 1(1): 44-46.
  7. Peer-reviewed Sawler, J., Stout, J.M., Gardner, K.M., Hudson, D., Vidmar, J., Butler, L., Page, J.E., Myles, S. (2015). 'The Genetic Structure of Marijuana and Hemp.' PLOS ONE, 10(8): e0133292.
  8. Peer-reviewed Cogan, P.S. (2020). 'The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy.' Expert Review of Clinical Pharmacology, 13(8): 835-845.

How this page was made

Generation history

May 7, 2026
Fact-check pass — raised 3 flags
May 6, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.